Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer

NCT01698918 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

202

Enrollment

INDUSTRY

Sponsor class

Conditions

Hormone Receptor Positive Breast Cancer

Interventions

DRUG: Everolimus
DRUG: Letrozole
DRUG: Exemestane
DRUG: Alcohol-free dexamethasone mouth rinse (Stomatitis sub-study)
DRUG: Standard of care to treat stomatitis (Stomatitis sub-study)

Sponsor

Novartis Pharmaceuticals